XORTX Therapeutics Inc (XRTX) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc (XRTX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting CA$5.68K (capex CA$2.84K plus investments CA$-2.84K) from operating cash flow of CA$1.57 Million. See XORTX Therapeutics Inc (XRTX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

CA$5.68K

Capex + Investments

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

XORTX Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for XORTX Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of XORTX Therapeutics Inc.

Annual Cash Flow Reinvestment Rate for XORTX Therapeutics Inc (2017–2017)

Year-by-year capital reinvestment analysis for XORTX Therapeutics Inc. See how financially flexible is XORTX Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2017	0.01x	CA$1.17K	CA$91.17K	CA$1.17K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow